France
· Delayed Price · Currency is EUR BIO-UV Group Statistics
Total Valuation
BIO-UV Group has a market cap or net worth of EUR 26.18 million. The enterprise value is 46.30 million.
| Market Cap | 26.18M |
| Enterprise Value | 46.30M |
Important Dates
The last earnings date was Friday, June 20, 2025.
| Earnings Date | Jun 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BIO-UV Group has 13.82 million shares outstanding. The number of shares has decreased by -0.58% in one year.
| Current Share Class | 13.82M |
| Shares Outstanding | 13.82M |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | +2.86% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 8.23% |
| Float | 13.65M |
Valuation Ratios
The trailing PE ratio is 834.73.
| PE Ratio | 834.73 |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 80.36 |
| P/FCF Ratio | 5.28 |
| P/OCF Ratio | 3.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.21, with an EV/FCF ratio of 9.33.
| EV / Earnings | 1,476.22 |
| EV / Sales | 1.20 |
| EV / EBITDA | 17.21 |
| EV / EBIT | 21.72 |
| EV / FCF | 9.33 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.64 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 8.92 |
| Debt / FCF | 4.83 |
| Interest Coverage | 2.75 |
Financial Efficiency
Return on equity (ROE) is 0.10% and return on invested capital (ROIC) is 2.27%.
| Return on Equity (ROE) | 0.10% |
| Return on Assets (ROA) | 1.94% |
| Return on Invested Capital (ROIC) | 2.27% |
| Return on Capital Employed (ROCE) | 4.13% |
| Revenue Per Employee | 259,660 |
| Profits Per Employee | 210 |
| Employee Count | 149 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.11 |
Taxes
In the past 12 months, BIO-UV Group has paid 60,926 in taxes.
| Income Tax | 60,926 |
| Effective Tax Rate | 66.02% |
Stock Price Statistics
The stock price has decreased by -14.14% in the last 52 weeks. The beta is 0.45, so BIO-UV Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -14.14% |
| 50-Day Moving Average | 1.90 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 41.55 |
| Average Volume (20 Days) | 6,811 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIO-UV Group had revenue of EUR 38.69 million and earned 31,361 in profits. Earnings per share was 0.00.
| Revenue | 38.69M |
| Gross Profit | 24.09M |
| Operating Income | 2.13M |
| Pretax Income | 92,287 |
| Net Income | 31,361 |
| EBITDA | 2.69M |
| EBIT | 2.13M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 3.87 million in cash and 23.99 million in debt, giving a net cash position of -20.12 million or -1.46 per share.
| Cash & Cash Equivalents | 3.87M |
| Total Debt | 23.99M |
| Net Cash | -20.12M |
| Net Cash Per Share | -1.46 |
| Equity (Book Value) | 32.69M |
| Book Value Per Share | 3.26 |
| Working Capital | 9.22M |
Cash Flow
In the last 12 months, operating cash flow was 6.90 million and capital expenditures -1.94 million, giving a free cash flow of 4.96 million.
| Operating Cash Flow | 6.90M |
| Capital Expenditures | -1.94M |
| Free Cash Flow | 4.96M |
| FCF Per Share | 0.36 |
Margins
Gross margin is 62.28%, with operating and profit margins of 5.51% and 0.08%.
| Gross Margin | 62.28% |
| Operating Margin | 5.51% |
| Pretax Margin | 0.24% |
| Profit Margin | 0.08% |
| EBITDA Margin | 6.95% |
| EBIT Margin | 5.51% |
| FCF Margin | 12.83% |
Dividends & Yields
BIO-UV Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.58% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.12% |
| FCF Yield | 18.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIO-UV Group has an Altman Z-Score of 1.25 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.25 |
| Piotroski F-Score | 6 |